UCB - 销售成本

股票价格
226.20
每天变化
-1.50 -0.66%
每月一次
-10.73%
每年
40.37%
Q2 预测
233.96




销售成本 更改 日
Alcon AG USD 1.2B 46M 2025-12
Almirall EUR 191.5M 2.29M 2025-12
Amarin USD 26.05M 1.41M 2025-12
argenx SE USD 149.69M 40.26M 2025-12
AstraZeneca USD -204M 3.48B 2026-03
Bayer EUR 4.5B 194M 2025-12
Galapagos EUR 455K 84.28M 2025-12
Genmab DKK 81M 23M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
GRIFOLS EUR 1.29B 163.12M 2025-12
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.29B 183M 2025-12
Novartis USD 3.54B 3M 2025-12
Orion EUR 163.7M 22.9M 2026-03
Recordati EUR 199.91M 20.12M 2025-09
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
UCB EUR 1.07B 146M 2025-12
Unibail Rodamco EUR 546.4M 9.4M 2025-12